Lumiracoxib (Compound)

Synonyms:Lumiracoxib, 220991-20-8, Prexige, COX-189, Lumaricoxib, COX 189, COX189, Prexige;COX 189, 2-(2-((2-chloro-6-fluorophenyl)amino)-5-methylphenyl)acetic acid, 2-((2-Chloro-6-fluorophenyl)amino)-5-methylbenzeneacetic acid, CHEMBL404108, DTXSID9049035, CHEBI:73044, {2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid, V91T9204HU, CGS-35189, NCGC00181795-01, Joicela, 2-((2-Chloro-6-fluorophenyl)amino)-5-methylphenyl)acetic acid, Benzeneacetic acid, 2-((2-chloro-6-fluorophenyl)amino)-5-methyl-, DTXCID4028961, 2-(2-(2-chloro-6-fluorophenylamino)-5-methylphenyl)acetic acid, 2-{2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid, Benzeneacetic acid, 2-[(2-chloro-6-fluorophenyl)amino]-5-methyl-, CAS-220991-20-8, Lumiracoxib (USAN/INN), lumiracoxibum, 2-[(2-Chloro-6-fluorophenyl)amino]-5-methylphenyl]acetic acid, 2-[2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl]acetic acid, 4llz, 4oty, LUR, Lumiracoxib- Bio-X, Prexige, Lumiracoxib, 2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid, 2-(2-(2-chloro-6-fluorophenylamino)-5-methylphenyl)aceticacid, LUMIRACOXIB [MI], LUMIRACOXIB [INN], LUMIRACOXIB [USAN], Lumiracoxib (COX-189), SCHEMBL4479, LUMIRACOXIB [MART.], LUMIRACOXIB [WHO-DD], MLS003882594, UNII-V91T9204HU, Lumiracoxib [USAN:INN:BAN], GTPL2897, HMS3264F19, HMS3651H08, HMS3884J22, (S)-Methyl2,3-dihydroxypropanoate, 2-[2-(2-chloro-6-fluoro-anilino)-5-methyl-phenyl]acetic acid, BCP06134, Tox21_113566, BDBM50207446, s2903, STL239146, AKOS015895138, Tox21_113566_1, AC-1738, CCG-213068, DB01283, KS-1302, SB19319, NCGC00181795-02, NCGC00181795-03, BL164650, HY-13507, SMR002529582, CS-0007130, FT-0601568, SW219769-1, D03714, D71097, AB01563279_01, A815920, EN300-24116087, Q413744, SR-01000930684, J-014493, SR-01000930684-2, 2-(2-((2-chloro-6-fluorophenyl)amino)-5-methylphenyl)aceticacid, 2-[2-[(2-Chloro-6-Fluoro-Phenyl)Amino]-5-Methyl-Phenyl]Acetic Acid

Pubchem:PUBCHEM:151166

Id:4b59291f-bfef-536f-b082-ea9cf05c179f

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Lumiracoxib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Lumiracoxib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Lumiracoxib.

Results found

Linked to

	Label	Description
	BRD-K26901728-001-05-4 Substance (Entity type)	A Substance
	DCSTRUCT ID 01618 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01618; PubChem_CID:151166, FILE=drugcentral_drug_01618.json)
	lumiracoxib (d4b4d9b7-cc7c-4704-a2ac-2a156c55db03) Collection (Entity type)	Metadatata for lumiracoxib
	Lumiracoxib negatively regulates RTN2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lumiracoxib negatively regulates AHNAK Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lumiracoxib positively regulates IGF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lumiracoxib positively regulates AKAP8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Lumiracoxib indication Degenerative polyarthritis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Lumiracoxib bioactivity Prostaglandin G/H synthase 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Lumiracoxib positively regulates CEACAM6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS